AKBA AKEBIA THERAPEUTICS INC
2026Q1 · CUSIP 00972D105 · Sector: Healthcare & Biotech
Neutral · No signal
Holders
170
Δ holders QoQ
+3
Breadth percentile
Top 50%
Whale holders
88
Δ whales
-12
Inst. holding value
$141M
New positions
36
Closed positions
33
Price momentum (1Q)
-15.8%
Put / Call
3/4
Breadth history (34 quarters)
Past Lit Events & Aftermath 8 lit events
| Period | Percentile | Next-1Q return | Next-2Q return |
|---|---|---|---|
| 2025Q3 | Top 20% | -33.0% | -42.6% |
| 2025Q1 | Top 9% | +8.6% | -37.1% |
| 2024Q1 | Top 11% | +29.6% | +55.7% |
| 2023Q2 | Top 16% | — | — |
| 2020Q2 | Top 9% | -76.2% | -56.8% |
| 2020Q1 | Top 19% | -11.9% | -79.0% |
| 2018Q4 | Top 6% | -17.6% | -26.3% |
| 2018Q1 | Top 8% | -25.0% | -28.7% |
Options Sentiment
Put holders
3
QoQ: +1
Call holders
4
QoQ: -1
See methodology →
Fundamentals
PE (TTM)
—
EPS (TTM)
$-0.08
EPS YoY
—
Revenue (TTM)
$0.2B
Revenue YoY
+25.7%
Net margin
-8.8%
ROE
-74.9%
Debt ratio
92.5%
FCF (TTM)
$60M
Dividend (TTM)
No dividend
Quarterly Revenue & EPS (4Y)
Quarterly figures; EPS split-adjusted, early quarters hidden when not calibrable
As of 2026-03-31 · SEC filings (XBRL)
Get the next update
2026Q2 holdings publish around Aug 15 — subscribe to receive the lists first.